Andrew S. Bomback, MD, MPH, is associate professor of medicine at Columbia University Irving Medical Center, where he is also the co-director of the Center for Glomerular Diseases. He completed his residency in internal medicine and fellowships in nephrology and clinical epidemiology at The University of North Carolina at Chapel Hill.

Dr Bomback has published more than 150 peer-reviewed articles on kidney disease, with a primary focus on glomerular diseases. He serves as a principal investigator or coinvestigator for clinical trials of immunoglobulin A nephropathy, complement 3 glomerulopathy, membranous nephropathy, lupus nephritis, and other glomerular diseases.

Carla M. Nester, MD, MSA, FASN, is the Jean Robillard Professor of Pediatric Nephrology and the division director of Pediatric Nephrology, Dialysis, and Transplantation at the University of Iowa Stead Family Children’s Hospital in Iowa City, IA. She is also the associate director of the Molecular Otolaryngology and Renal Research Laboratories (MORL) at the University of Iowa, the largest combined clinical and research laboratory in North America with a focus on complement biology.

Dr Nester is a National Institutes of Health–funded, tenured faculty member with a translational research program focusing on rare complement-mediated kidney diseases. In addition, she is the primary clinical investigator for the University of Iowa C3 Glomerulopathy Natural History Study, which includes one of the largest cohorts of patients with rare C3 glomerulopathy available to research. Finally, Dr Nester is a clinical trialist; her clinical practice has become a hub for bringing the new generation of anticomplement therapeutics to a rare disease population.

Samir V. Parikh, MD, FASN, is an associate professor of medicine in the Division of Nephrology at The Ohio State University in Columbus. He joined The Ohio State University faculty in 2011. 

Dr Parikh is a clinician, translational researcher, and clinical trialist focused on improving the management and outcomes for patients with glomerular disorders and thrombotic microangiopathies. His research has centered on uncovering novel biomarkers of disease and optimizing the use of kidney biopsy to inform management decisions in kidney diseases. He has authored several manuscripts on these topics. Additionally, Dr Parikh is currently and has previously been the principal investigator for numerous trials of novel therapeutics for glomerular diseases, such as lupus nephritis.